Karen Lasch

Statistics

Publications

Citations

2.2K

H-Index

Active since

2012

Affiliations

Takeda (United States)(Current)

Deerfield (United States)

Icahn School of Medicine at Mount Sinai

University of California San Diego

Western University

Karen Lasch is an author at Takeda (United States) specializing in inflammatory bowel disease, pharmacotherapy, and inflammatory bowel disease therapy.

Publications per year

2012–2025

Publications

Vedolizumab as Induction and Maintenance Therapy for Crohnʼs Disease in Patients Naïve to or Who Have Failed Tumor Necrosis Factor Antagonist Therapy

Bruce E. Sands, William J. Sandborn, Gert Van Assche et al. · Inflammatory Bowel Diseases · 2016 · 184 citations

Pharmacy, Pharmacology, Pharmacotherapy +15

Open: Vedolizumab for Ulcerative Colitis: Treatment Outcomes from the VICTORY Consortium

Neeraj Narula, Farhad Peerani, Joseph Meserve et al. · The American Journal of Gastroenterology · 2018 · 175 citations

Medicine, Internal Medicine, Pharmacotherapy +15

Development and Validation of a Scoring System to Predict Outcomes of Vedolizumab Treatment in Patients With Crohn’s Disease

Parambir S. Dulai, Brigid S. Boland, Siddharth Singh et al. · Gastroenterology · 2018 · 149 citations · Full text

Medicine, Clinical Sciences, Pharmacotherapy +14

Vedolizumab exposure in pregnancy: outcomes from clinical studies in inflammatory bowel disease

Uma Mahadevan, Séverine Vermeire, Karen Lasch et al. · Alimentary Pharmacology & Therapeutics · 2017 · 128 citations · Full text

Medicine, Immunology, Obstetrics +15

Risk of developing colorectal cancer and benign colorectal neoplasm in patients with chronic constipation

A. Guérin, Reema Mody, Beverly Fok et al. · Alimentary Pharmacology & Therapeutics · 2014 · 117 citations

Medicine, Biostatistics, Oncology +15

1–5 of 37